But since, we discuss risk-reducing surgery on the contralateral breast for those patients with pathogenic variants of BRCA1/2 based on the risk of about 30% to develop CBC, the presented data is of crucial importance. The gene discussed is BRCA1; the disease is complete blood cell count.